Free Trial
→ Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (From Colonial Metals) (Ad) Free LXEO Stock Alerts

Lexeo Therapeutics (LXEO) Institutional Ownership

Lexeo Therapeutics logo
$6.12 +0.10 (+1.66%)
(As of 11/20/2024 ET)
Compare

Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)

Current
Institutional Ownership
Percentage
60.67%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$129.08M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$26.76M
Get LXEO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LXEO Institutional Buying and Selling by Quarter

Lexeo Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/16/2024 Geode Capital Management LLC553,247$5.00M0.0%+86.5%1.673%
11/15/2024 Frazier Life Sciences Management L.P.1,250,786$11.31M0.5%N/A3.783%
11/15/2024 Barclays PLC50,210$454K0.0%+162.2%0.152%
11/15/2024 Jane Street Group LLC35,677$323K0.0%+33.3%0.108%
11/15/2024 Wellington Management Group LLP51,892$469K0.0%+134.8%0.157%
11/15/2024 State Street Corp253,946$2.30M0.0%+29.4%0.768%
11/15/2024 RA Capital Management L.P.546,554$4.94M0.1%-18.8%1.653%
11/15/2024 Point72 Asset Management L.P.370,407$3.35M0.0%N/A1.120%
11/15/2024 Polar Asset Management Partners Inc.59,800$541K0.0%-8.4%0.181%
11/15/2024 Ikarian Capital LLC257,216$2.33M0.3%N/A0.778%
11/15/2024 Jacobs Levy Equity Management Inc.30,346$274K0.0%N/A0.092%
11/15/2024 Janus Henderson Group PLC3,763,195$34.00M0.0%+18.9%11.383%
11/14/2024 PDT Partners LLC26,608$241K0.0%N/A0.080%
11/14/2024 Braidwell LP728,777$6.59M0.2%-47.3%2.204%
11/14/2024 Eventide Asset Management LLC1,855,986$16.78M0.3%-44.9%5.614%
11/14/2024 Verition Fund Management LLC777,320$7.03M0.0%+84.5%2.351%
11/14/2024 Vestal Point Capital LP850,000$7.68M0.6%+1.2%2.571%
11/14/2024 MetLife Investment Management LLC14,223$129K0.0%+121.5%0.043%
11/13/2024 BNP Paribas Financial Markets5,541$50K0.0%+184.2%0.017%
11/12/2024 Charles Schwab Investment Management Inc.63,874$577K0.0%+107.0%0.193%
10/24/2024 Novo Holdings A S1,122,581$10.15M0.5%-22.6%3.407%
10/23/2024 Values First Advisors Inc.7,446$67K0.0%N/A0.023%
8/20/2024 Novo Holdings A S1,450,500$23.27M1.2%-11.5%4.403%
8/1/2024 Rhumbline Advisers13,357$214K0.0%+37.3%0.041%
7/26/2024 Bank of New York Mellon Corp31,806$510K0.0%+12.3%0.097%
5/17/2024 RA Capital Management L.P.660,938$10.36M0.1%N/A2.006%
5/17/2024 Artal Group S.A.801,716$12.57M0.3%+32.9%2.434%
5/16/2024 Janus Henderson Group PLC2,540,785$39.80M0.0%+9.0%7.713%
5/14/2024 American International Group Inc.5,053$79K0.0%N/A0.015%
5/10/2024 Vanguard Group Inc.481,755$7.55M0.0%+15.8%1.462%
5/1/2024 BNP Paribas Financial Markets4,781$75K0.0%N/A0.015%
4/29/2024Cornell University126,258$1.98M30.0%N/A0.383%
2/20/2024 Eventide Asset Management LLC3,002,831$40.30M0.7%N/A11.268%
2/15/2024 Omega Fund Management LLC2,157,623$28.96M23.5%N/A8.096%
2/15/2024 Blackstone Inc.696,110$9.34M0.0%N/A2.612%
(Data available from 1/1/2016 forward)

LXEO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LXEO shares?

During the previous two years, 30 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($34.00M), Omega Fund Management LLC ($28.96M), Eventide Asset Management LLC ($16.78M), Artal Group S.A. ($12.57M), Frazier Life Sciences Management L.P. ($11.31M), Novo Holdings A S ($10.15M), and Blackstone Inc. ($9.34M).Learn more on LXEO's institutional investors.

What percentage of Lexeo Therapeutics stock is owned by institutional investors?

60.67% of Lexeo Therapeutics stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings.

Which institutional investors have been buying Lexeo Therapeutics stock?

Of the 27 institutional investors that purchased Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.00M), Omega Fund Management LLC ($2.16M), Frazier Life Sciences Management L.P. ($1.25M), Janus Henderson Group PLC ($809.25K), Blackstone Inc. ($696.11K), RA Capital Management L.P. ($660.94K), and Point72 Asset Management L.P. ($370.41K).

How much institutional buying is happening at Lexeo Therapeutics?

Institutional investors have bought a total of 10,502,084 shares in the last 24 months. This purchase volume represents approximately $129.08M in transactions.

Which Lexeo Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Lexeo Therapeutics stock in the last 24 months: Eventide Asset Management LLC ($1.51M), Braidwell LP ($653.70K), Novo Holdings A S ($515.72K), RA Capital Management L.P. ($126.16K), and Polar Asset Management Partners Inc. ($5.50K).

How much institutional selling is happening at Lexeo Therapeutics?

Institutional investors have sold a total of 2,814,240 shares in the last 24 months. This volume of shares sold represents approximately $26.76M in transactions.


Related Companies

This page (NASDAQ:LXEO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored